Skip to Content

BMS 213 (Daklinza 30 mg)

Generic Name: daclatasvir

Pill with imprint BMS 213 is Green, Five-sided and has been identified as Daklinza 30 mg. It is supplied by Bristol-Myers Squibb Company.

Daklinza is used in the treatment of hepatitis c and belongs to the drug class NS5A inhibitors. Daklinza 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 213

Daklinza 30 mg BMS 213

Daklinza

Generic Name
daclatasvir
Imprint
BMS 213
Strength
30 mg
Color
Green
Shape
Five-sided
Availability
Prescription only
Drug Class
NS5A inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb Company
National Drug Code (NDC)
00003-0213

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.